Dr.Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital
Ankara, Yenimahalle/Ankara, 06200, Turkey (Türkiye)
NCT Number: NCT07325617
This study is a one-time, questionnaire-based survey of adults attending a urology outpatient clinic. The investigators will examine whether patients who use AI chat tools based on large language models (LLMs), such as ChatGPT, before seeking care differ from non-users in (1) anxiety, (2) satisfaction with the clinic visit, and (3) awareness/understanding of their health condition.
Participants who provide written informed consent will complete a brief survey during their clinic visit (about 5-7 minutes). The survey includes a standardized anxiety scale (GAD-7), visual analog scales (0-10) for anxiety before and after the visit, satisfaction, and disease awareness, as well as questions about AI/LLM knowledge and use. Treating clinicians will not have access to participants' survey responses, and participation will not affect clinical care.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Ankara, Yenimahalle/Ankara, 06200, Turkey (Türkiye)
The TALK-U study is a cross-sectional, observational survey conducted in the urology outpatient clinic of Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. The primary exposure is self-reported AI/LLM knowledge and use for health information (e.g., whether participants have used ChatGPT or similar tools, frequency, awareness of AI, and purpose of use). The primary outcome is anxiety measured by GAD-7 at the time of the clinic encounter. Secondary outcomes include (i) anxiety assessed on a 0-10 visual analog scale before and after the visit, (ii) outpatient visit satisfaction (0-10 VAS), and (iii) perceived disease awareness/understanding (0-10 VAS).
Eligible adult first-time urology outpatients who can complete the survey independently and provide informed consent will be invited during a 2-month recruitment period. Analyses will compare outcomes between AI/LLM users and non-users and explore associations with age group (<40, 40-60, >60), education level, and urology subspecialty category. Data will be analyzed using appropriate parametric/nonparametric tests depending on distribution, with p < 0.05 considered statistically significant.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 0 (immediately before the outpatient visit)
Self-rated anxiety on a 0-10 visual analog scale (VAS), where 0 indicates no anxiety and 10 indicates the highest possible anxiety. This measure reflects visit-related state anxiety prior to clinician encounter.
Time frame: Day 0 (immediately after the outpatient visit)
Self-rated anxiety on a 0-10 VAS (0 = none, 10 = highest).
Time frame: Day 0 (immediately after the outpatient visit)
Self-rated satisfaction with the outpatient visit on a 0-10 VAS (0 = not satisfied at all, 10 = maximum satisfaction).
Time frame: Day 0 (during the outpatient clinic visit)
Self-rated awareness/understanding of one's condition on a 0-10 VAS (0 = none, 10 = complete).
Time frame: Day 0 (at enrollment; prior to or during the clinic visit)
Total score on the 7-item GAD-7 questionnaire (range 0-21; higher scores indicate greater generalized anxiety symptoms). This measure will be used to account for baseline anxiety (trait-like symptoms) and to adjust analyses of VAS-based state anxiety out
Contact information is provided by the study sponsor or research team.
Mehmet Duvarcı, MD
CONTACT
+90 312 336 09 09 ext. 5616
Tuncel Uzel, MD
CONTACT
+90 312 336 09 09 ext. 5622
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Other
The TALK-U Study: Tracking AI/LLM Knowledge and Use in Urology Outpatients and Its Association With Anxiety, Satisfaction, and Health Awareness-A Cross-Sectional Study
Acronym: TALK-U
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07668050
Anxiety, Anxiety Disorders
Clermont-Ferrand, France
View Trial DetailsNCT07599358
Anxiety, Anxiety Disorders
View Trial DetailsNCT07553624
Acute Pain, Anxiety
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07424482
Acute Coronary Syndrome, Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Berlin, Germany
View Trial Details